medigraphic.com
SPANISH

Enfermedades Infecciosas y Microbiología

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 3

<< Back

Enf Infec Microbiol 2025; 45 (3)

Catheter-related bloodstream infection due to Staphylococcus capitis multidrugresistant. Case report in Mexico

Martínez-Perale K, Galván-Guerra G, Rodríguez-García R, Sosa-Hernández Ó
Full text How to cite this article

Language: Spanish
References: 8
Page: 163-164
PDF size: 122.47 Kb.


Key words:

Staphylococcus capitis, multidrug resistance, chronic kidney disease.

ABSTRACT

Staphylococcus capitis is a coagulase-negative staphylococcus species. It is a commensal bacterium of the skin, primarily the scalp. It is an unusual agent with a multidrug-resistant antimicrobial susceptibility profile. Multidrug-resistant S. capitis (MDR-SC) has been identified in catheter-related bloodstream infections in neonatal intensive care units in European countries. We present the clinical case of a male with chronic kidney disease undergoing hemodialysis. Catheter line infection was suspected, and S. capitis was isolated in blood culture. Treatment with vancomycin was initiated, with good outcome.


REFERENCES

  1. Tchana-Sato, V., Hans, G., Frippiat, F., Zekhnini, I., Dulgheru,R., Lavigne et al., “Surgical management ofStaphylococcus capitis prosthetic valve infective endocarditis:Retrospective review of a 10-year single centerexperience and review of the literature”, J Infect PublicHealth, 2020, 13 (11): 1705-1709.

  2. Moore, G., Barry, A., Carter, J., Ready, J., Wan, Y., Elsayed,M. et al., “Detection, survival, and persistenceof Staphylococcus capitis nrcs-a in neonatal units in England”,J Hosp Infect, 2023, 140: 8-14.

  3. Laurent, F. y Butin, M., “Staphylococcus capitis andnrcs-a clone: the story of an unrecognized pathogen inneonatal intensive care”, Clin Microbiol Infect, 2019, 25(9): 1081-1085.

  4. Ibrahim, R., Waked, R., Choucair, J., Aubry, A., Laurent,F., Martins-Simoes, P. et al., “Linezolid-resistant Staphylococcuscapitis isolate”, Infectious Diseases Now,2022, 52: 175-182.

  5. Szekat, C., Josten, M., Rickmeyer, J., Crüsemann, M. yBierbaum, G., “A Staphylococcus capitis strain with unusualbacteriocin production”, Microb Biotechnol, 2023,16 (11): 2181-2193. doi: 10.1111/1751-7915.14356.Epub: 18 de octubre de 2023. pmid: 37850940; pmcid:pmc10616647.

  6. Sitges-Serra, A. y Girvent, M., “Catheter-related bloodstreaminfections”, World J Surg, 1999, 23 (6): 589-595.doi: 10.1007/pl00012352. pmid: 10227929.

  7. Han, X., Zou, G., Liu, J., Yang, C., Du, X., Chen, G. et al.,“Mechanisms of linezolid resistance in Staphylococcuscapitis with the novel mutation c2128t in the 23s rrnagene in China”, bmc Microbiol, 2022, 22 (1): 203.

  8. Chavignon, M., Coignet L., Bonhomme, M., Bergot,M., Tristan, A., Verhoeven, P. et al., “Environmentalpersistence of Staphylococcus capitis nrcs-a in neonatalintensive care units: role of biofilm formation, desiccation,and disinfectant tolerance”, Microbiol Spectr,2022, 10 (6): e0421522.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Enf Infec Microbiol. 2025;45